Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate
Denosumab May Help Prevent Bone Loss
Past Highlights
Results:
1 -4 of 4
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Title
Phase
Protocol IDs
Antineoplaston Therapy in Treating Patients With Brain Tumors
Phase II
BC-BT-9
NCT00003457
Temozolomide in Treating Patients With Invasive Pituitary Tumors
Phase II
UCLA-06-12-080
06-12-080, SPRI-UCLA-06-12-080, 07-05-077-01, NCT00601289
Rosiglitazone in Treating Patients With Newly Diagnosed ACTH-Secreting Pituitary Tumor (Cushing's Disease)
Phase II
UCLA-0612080-01
06-12-080-01, NCT00612066
Rosiglitazone in Treating Patients With Pituitary Tumors
Phase II
UCLA-0411082-03
04-11-082-03, NCT00616642
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute